Search

Docetaxel and a novel bcl-2 antisense oligonucleotide for enhanced apoptosis in prostate cancer cells: A potential therapeutic strategy

7667-7679 2025-08-31

Reyhaneh Ardestani, Mohsen Sedaghat Janaghard, Ali Akbar Saffar Moghadam, Masoumeh Rajabibazl, Marzieh Motallebi, Rezvaneh Ghadyani, Shahrzad Soleimani , Abolfazl Movafagh

Biomolecular Condensates: Molecular Mechanisms, Advanced Technologies, and Translational Therapeutic Strategies for Prion Diseases

8937-8945 2026-08-31

Jeremiah Vandy

Amyloid Beta and Tau Aggregation: The Etiology and Potential Pharmaceutical Approaches for Alzheimer’s Disease

7708-7722 2025-09-30

Pushpendra Soni, Syed Misbahul Hasan, Shom Prakash Kushwaha, Kuldeep Singh, Arun Kumar, Abdul Hafeez, Suvaiv, Samman, Salman Khan

LncRNA-NONHSAT192404.1 Regulates miR-518a-3p to Inhibit Triple-Negative Breast Cancer Progression via the PI3K/AKT Pathway

7633-7643 2025-08-31

Huachao Yang, Lin Gan, Yu Zheng, Jie Min, Zhifeng Xiong, Ting Wang, Shisi Hu, Gang Lv

Search Results

Docetaxel and a novel bcl-2 antisense oligonucleotide for enhanced apoptosis in prostate cancer cells: A potential therapeutic strategy

Biomolecular Condensates: Molecular Mechanisms, Advanced Technologies, and Translational Therapeutic Strategies for Prion Diseases

Amyloid Beta and Tau Aggregation: The Etiology and Potential Pharmaceutical Approaches for Alzheimer’s Disease

LncRNA-NONHSAT192404.1 Regulates miR-518a-3p to Inhibit Triple-Negative Breast Cancer Progression via the PI3K/AKT Pathway